Relay Therapeutics Inc (RLAY) is near the top in its industry group according to InvestorsObserver. RLAY gets an overall rating of 62. That means it scores higher than 62 percent of stocks. Relay Therapeutics Inc gets a 76 rank in the Biotechnology industry. Biotechnology is number 36 out of 148 industries.
RLAY has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on RLAY!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Relay Therapeutics Inc Stock Today?
Relay Therapeutics Inc (RLAY) stock is trading at $17.56 as of 3:17 PM on Tuesday, Jun 21, a gain of $1.43, or 8.9% from the previous closing price of $16.12. The stock has traded between $15.87 and $17.87 so far today. Volume today is below average. So far 745,263 shares have traded compared to average volume of 1,108,195 shares.
Click Here to get the full Stock Report for Relay Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
